IGNITE: Assay Development & Neurotherapeutic Agent
Direct costs: max $499,000/year; $750,000 total fund - October 20, 2027
National Institutes of Health (NIH)-R61/R33 Exploratory/Developmental Phased Award*This NOFO funds assay development and screening to identify therapeutic agents for neurological or neuromuscular disorders. Part of IGNITE; PEDP required.
